Caris Expands Clinical Trial Network to 600+ Sites, Matches 71,000 Patients
Caris Life Sciences has deployed its Right-In-Time solution at over 600 community oncology sites, matching 71,000 patients to 30+ precision oncology trials in as few as five days. The program leverages WES, WTS and IHC across 23,000 genes and enlists 2,200 investigators to streamline trial enrollment.
1. Right-In-Time Solution Deployment
Caris has activated its RIT clinical trial solution at over 600 community and regional oncology sites, enabling trial activation in as few as five days and patient enrollment within two weeks.
2. Molecular Profiling Integration
Every patient undergoes WES, WTS and IHC analysis covering 23,000 genes, with results automatically matched against 30+ active trials and 80+ biopharma partners via a proprietary platform.
3. Network Scale and Reach
The network comprises 2,200 investigators across 600+ U.S. and Puerto Rico sites, with over 71,000 patients identified for potential trial participation through the program.
4. Streamlined Trial Operations
Clinical Trial Navigators conduct eligibility assessments within 24–48 hours, while Caris manages contracting, site qualification and IRB processes to preserve continuity of care and reduce travel burdens.